JFIFC    $ &%# #"(-90(*6+"#2D26;=@@@&0FKE>J9?@=C  =)#)==================================================" }!1AQa"q2#BR$3br %&'()*456789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz w!1AQaq"2B #3Rbr $4%&'()*56789:CDEFGHIJSTUVWXYZcdefghijstuvwxyz ?23ڤDOXtU U8HSy4 8i\,4*NT#ԛpi(8@&ÐOZC 18@4rx2$qC/9A9ǽ;f t,?EV>eL`d\֩56) )yQ@;*PRT5T1x^2x6:*q(杴ۊP M +;bUY`I+l<#>w ,Fq=1^2F3j#.aԦEI*]kO-Œpf> o>+\!7B4~F \!<مg\xCÚҵ߇j~;RF! ^F=k:[Ǧ[Y\M0 u#56&࿕ahNV A#lrO늺Pl+N=O@<5 c6r+JG+^wQxurghvASd#4IXC&I7Ųhr[XːrVU ޹}fK5bć #zQwd9_ nzY.%?rrNzM_^t:[I$N0x:|-YL!޳M:C2v'YKX]λR[+68 Gc↽Ih~xr>\gmbmB[eqC,r6EЭt10E;ns“4 Uյ6.#`8^֙;3F $$r t+f-̶'`;=)}Q2\=w]1s +3tHi:|Pt BיMg<ѭdV t[|G,L[ۿ32]AVl?5.< Y9 ?:-$7ӎ:խ=| xߺڲ$㱬SQt-vG/_S(aǸ>U<5in!27|>Uݜ򍝎DdJr 1n?5;g1ܬ:];'Q&Ƹ8?\5±&E5a7'vk*H!*FG?)޴< XbD'8].k=CRΚ&14CMQMnRzےwv< ~) z$:CrF_#x4ںQܻ\2,S(!vגjZs;6w9;LWj K)=^yqh 2p泣>WB-cG̵wQѐԷ15]tRGyJ |ǹ=Gjƺ|0F3ˑN.; N<ױch爕20^mu6[g{wE`Wgx-|3u3RXr66&_ lT 3ѿqSJ~E*;wZZ\]^ʻpKg?kf[˨wyn.+cz]w6s/_ۻ]T<1k HG~#Y6m5V;0y{[r$Po[I[y`QFƖZsgZl8=ՄDKG|AҶ߱43Xu3 ]!s[V5J!6yJĖqBsc=u D#QNhI۪-2;w)}=jDJ%#~!EA3$ިImIm*ץu%vyk)խqcH#kFS3^u]u'4`Wܫ>*?7]Dp wwn5e"h3W-BƄr:LFVi z7hbi/nǎCl#I'/v^'d7rrTғsA@~[zC9ǜ\p?Rg33ӵ3F?yNkN;;ߝGĒITXUI152(⦸F<6׎خZMFF23ׯ57Yg[nG| ^0H]Fg<3 v(~*h[{YPy?.|A2jRKצVj*_u vE}@B-B9e6mӦG Wsp-"`4}A+W`;iMoO8qbrLjxbU8Š $5"A1R*SFxhJ]F1ITGZdD7^ Y< 9i͘.t_ [Y$ˉ&*1e1'h̉p&PbG_sjǖ:J<ϥ `2flY1)4k3^kUw”Fv}GZ4 ϧڲQ*tF6nb_j%Xvlg m4Ƕh xKK\V[,lzFx'<~^6*1Lxh5dXsk29*D:o^I` iO4rUNxL.]>E8GP)ix5"#$֜"ih穤y@u9#'jC{s4b :(BjRz #P>U+jB#)Upx9\b c#qKqSykךC')]=7Bjp?F.00zcM'A8曁"#ע\LzpG }뮝emHqvM~uF1¨ED$5b2Up5ks+!%bHCz֕ yRTt P8hSݹqz~>&[$ }rGKbymYR(c#ROLWx31ÿtwYhՓ9]f KohMK|sɨG!x?*I$e80xxV5̪TѹU33ԭk~-dXC>CԾ0uI88=1^6aXmX8?z×[ Үۜ+9Thɤ|Eω-Y`b2qrx3+Ҿ(]|H|A׎A=΢csWeGwvU[$n2}zT̀[U-fLKV[~QU˴*nח g;$vk9A\|5k0Cl3IKzjCJœ#r=V m 0pKb;s=Fs튻>fk i4<꺗K/OF~}+892(FU*kv.O-o Qq#>ҋ} p njS@ ?^±5dT%aRF+ɅiJZl !MtQG 1(@s֊fZ^~am(PGw|ZkSu7&TacSG5q!CzyBiVM_kbFvK60C [O2dKQHH~_$u>ߍz*-oH\/kC>m_Bב*>μVW^pTpkO-\Z'ڵ%+c?1+-.ݦr7{?ʑ2mvӾԈBb2/˟Ƌ0v_ư#9bsr6 hq=N8V/8ր!/) s6^ YW1'=+JWg 1Tr$py֬2ڤHwj͐HZ6ӧJ2G|ԫ\`qMCqT31P嗜v5VmCoȊ14lwJ[-%bJ.9:(fHΏa3_~}:k,K!h_Qog`{37Sq_9o6CxI(|8PGeCosi^J V"`` 30MOJYڴ[񅁀bN?ef݋@R7w͉w$5݆QVҿI)ioƴ.7_mPs&6K6zOUaK!cּ\HlU,4Q ݷ䈩k2MB.+_"E8fWeAb y;&G$lIiVmçXޮ,ryiMLI+^ )"Ӄ:㲊F81Ozz:~_~jO<$.$dgOƝ[I'ʹ~j? :aVGR82Az=4`OS6q{b^U .HݑH=0*_*\zb(A (֥Vx 튜&yS:P{JqYG&ʦ{ (9n¨]]jf M;x(TF|OZQ&u§ E_*ivӣrAѻq% 7GU&<$d'< ONKaj0QBέxygrPHϻy枤kHEEY꺳dEA-j*,hyDyatQEcvU:|P|hW`?E/fPH|; ( f9O*tQE` wP}qSy4y{Ҋ(w;482|EUL.GlQERlDw1<9c(v1yI4YER|T$|E]g=U!GSQLF Ib?QEas tests of liver or kidney function." Kraemer examined active college students at Penn State after a heavy work out. He also found no side effects from the use of creatine. He examined hormone levels, blood profiles and muscle biopsies. Participants also filled out questionnaires regarding any side effects such as cramping, diarrhea, nausea. None were reported. Not only has Kraemer thoroughly examined creatine, he also used it when he was a competitive athlete as did his 17-year-old daughter when she played high school tennis and his 15-year-old son when he was weight lifting. Again, no adverse side affects. Creatine does have one well-documented side effect. It causes an increase in muscle mass. When taken as prescribed it has the capacity to increase body weight by as much as seven pounds in five days.<br>Are there any long term effects? The long term effect of creatine has never been studied. However, creatine has been used in the past and without incident. Athletes in the 1940s and 1950s used it until steroids became available. They switched to steroids because they got results much faster. The Eskimos ingest up to four grams of creatine per day through their hig